Popular
Polydeoxyribonucleotide in a Bottle Depends on Formulation Science
Modern AestheticsPolydeoxyribonucleotide in a Bottle Depends on Formulation Science
Maureen Ike, BSc
Diagnosing Hidden Profit Losses in Aesthetic Medicine Practices
Modern AestheticsDiagnosing Hidden Profit Losses in Aesthetic Medicine Practices
Harparam Sandnhu
Understanding Filler Fatigue and Guiding Patients Toward Natural Outcomes
Modern AestheticsUnderstanding Filler Fatigue and Guiding Patients Toward Natural Outcomes
Vince Bertucci, MD, FRCPC
Biostimulation and Bioregeneration in Injectable Aesthetics
Modern AestheticsBiostimulation and Bioregeneration in Injectable Aesthetics
Rafael Mojica, DO
Kanthi Bommareddy, MD
Tara Howard, DO
Arash Babadjouni, DO
Shino Bay Aguilera, DO
Sara Hogan, MD, FAAD
Tafamidis Prescribing Updates in ATTR-CM: Long-Term Therapy Following Appropriate Diagnosis
Spotlight On ATTR-CMTafamidis Prescribing Updates in ATTR-CM: Long-Term Therapy Following Appropriate Diagnosis
Programs
Polydeoxyribonucleotide in a Bottle Depends on Formulation Science
Modern AestheticsPolydeoxyribonucleotide in a Bottle Depends on Formulation Science
Maureen Ike, BSc
Diagnosing Hidden Profit Losses in Aesthetic Medicine Practices
Modern AestheticsDiagnosing Hidden Profit Losses in Aesthetic Medicine Practices
Harparam Sandnhu
Understanding Filler Fatigue and Guiding Patients Toward Natural Outcomes
Modern AestheticsUnderstanding Filler Fatigue and Guiding Patients Toward Natural Outcomes
Vince Bertucci, MD, FRCPC
Sara Hogan, MD, FAAD
Serum and Urine Immunofixation Electrophoresis in ATTR-CM: Exclusion Before Confirmation
Spotlight On ATTR-CMSerum and Urine Immunofixation Electrophoresis in ATTR-CM: Exclusion Before Confirmation
Cardiac MRI in ATTR-CM: Role in Tissue Characterization and Diagnostic Workup
Spotlight On ATTR-CMCardiac MRI in ATTR-CM: Role in Tissue Characterization and Diagnostic Workup
Clinical Practice
Advancing Bone Health: Key Insights from ISO 2026
Boning Up on OsteoporosisAdvancing Bone Health: Key Insights from ISO 2026
Marshall Miller
Ami R. Patel
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Virtual EventWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
October 07, 2026
06:00 PM - 07:00 PM CEST
On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
MinuteCE®On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
Ticiana Leal, MD
Clinical Evidence on Emerging Antigen-Directed Strategies in ES-SCLC
MinuteCE®Clinical Evidence on Emerging Antigen-Directed Strategies in ES-SCLC
Ticiana Leal, MD
Doctors Lounge
Optimizing Medical Affairs Approaches with CME Best Practices
MAPSChatsOptimizing Medical Affairs Approaches with CME Best Practices
Matt Birnholz, MD
Karen Roy, MSc
Inside Medical Affairs: MSL Insights on AI, Strategy, and Impact
MAPSChatsInside Medical Affairs: MSL Insights on AI, Strategy, and Impact
Matt Birnholz, MD
Brandon Young, PhD
Designing Smarter Insight Frameworks in Medical Affairs
MAPSChatsDesigning Smarter Insight Frameworks in Medical Affairs
Matt Birnholz, MD
Tony Page
Turning Insight into Action: The Expanding Role of Medical Affairs
MAPSChatsTurning Insight into Action: The Expanding Role of Medical Affairs
Matt Birnholz, MD
Michael DeLuca, PharmD, MBA, MSRA
Navigating Vaccine Communication: A Medical Affairs Perspective
MAPSChatsNavigating Vaccine Communication: A Medical Affairs Perspective
Matt Birnholz, MD
Abigail Sporer, PhD, MBA
Earlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
The ConvergenceEarlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
Brian P. McDonough, MD, FAAFP
Adrian Noriega de la Colina, MD, PhD
Arvid E. Gollwitzer
CME
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
MinuteCE®Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
Neal Ready, MD, PhD
The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
MinuteCE®The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
Neal Ready, MD, PhD
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Industry Feature
Redefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Medical Industry FeatureRedefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Priya Vakharia, MD
Andrew Moshfeghi
Seeing the Full Picture of ADHD: Beyond Core Symptoms
Innovations In MedicineSeeing the Full Picture of ADHD: Beyond Core Symptoms
Andrew J. Cutler, MD
Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC
Ana’s Story – A Real Patient Living With Ulcerative Colitis
Medical Industry FeatureAna’s Story – A Real Patient Living With Ulcerative Colitis
Ana, A Real Patient Living With Ulcerative Colitis
Lukasz Kwapisz, MD
Long-Term Efficacy and Safety Data in Ulcerative Colitis
Medical Industry FeatureLong-Term Efficacy and Safety Data in Ulcerative Colitis
Erica Cohen, MD
Addressing Adherence Challenges in Moderate-to-Severe Plaque Psoriasis Management
Medical Industry FeatureAddressing Adherence Challenges in Moderate-to-Severe Plaque Psoriasis Management
Charles Turck, PharmD, BCPS, BCCCP
Matthew Brunner, MHS, PA-C
Douglas DiRuggiero, DMSc, PA-C
Two Lenses on Migraine: Managing Incomplete Acute Treatment Response
Innovations In MedicineTwo Lenses on Migraine: Managing Incomplete Acute Treatment Response
Fallon Schloemer, DO
Susan Hutchinson, MD